SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-23-008367
Filing Date
2023-11-20
Accepted
2023-11-20 17:26:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT cns_s3.htm S-3 157335
2 OPINION cns_ex0501.htm EX-5.1 7370
3 CONSENT cns_ex2301.htm EX-23.1 2631
4 CALCULATION OF FILING FEE TABLES cns_ex107.htm EX-FILING FEES 12460
5 GRAPHIC image_001.jpg GRAPHIC 3287
  Complete submission text file 0001683168-23-008367.txt   185450
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275671 | Film No.: 231423726
SIC: 2834 Pharmaceutical Preparations